Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by stockman6767on Aug 23, 2020 8:01pm
307 Views
Post# 31444056

Convalescent Plasma not a big deal for LMNL - no money in it

Convalescent Plasma not a big deal for LMNL - no money in itIf LMNL gets a pump tomorrow on the basis of Trump's announcement today about the  FDA authorization for the use of Convalescent Plasma to treat Covid, that will be only due to uninformed retail investors ready to jump on any Covid investment. They will  be very disappointed when eventually this does not produce any significant revenue for LMNL who is part of the Covid consortium.

Why? Because while the treatment may work, all it amounts to is collecting blood from donors and then transfusing the same blood into the patient. There is no processing or secret that makes iit work. So there will not be any real money coming from the simple resale of  unprocessed blood plasma. So anyone who understands the treatment realizes that there is no big revenue for LMNL to come as a result of this treatment even if it works and is great for the patients.
<< Previous
Bullboard Posts
Next >>